Emergent buying & selling facilities
Emergent BioSolutions believes it can reduce its debt, cut operating expenses and gain more flexible production capacity by reorganising its manufacturing operations.
Archives for August 9, 2009
Appointments at inVentiv and GVK Biosciences – People on the move
Outsourcing-Pharma presents its latest round of movements in the pharmaceutical outsourcing sector, including appointments at inVentiv and GVK Biosciences.
FDA strengthens disqualify & debar actions
The US Food and Drug Administration (FDA) has enhanced its debarment and disqualification procedures to ensure clinical trial investigators meet legal requirements.
Downstream demand helps Millipore’s Q2
Demand for downstream processing products from biotechs drove the continued recovery of Millipore’s bioprocessing division in Q2 but operating income remained flat.